BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jafarzadeh A, Nemati M, Saha B, Bansode YD, Jafarzadeh S. Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons. Viral Immunol 2021;34:307-20. [PMID: 33147113 DOI: 10.1089/vim.2020.0076] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kirou KA, Dall`era M, Aranow C, Anders H. Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment. Front Immunol 2022;13:980079. [DOI: 10.3389/fimmu.2022.980079] [Reference Citation Analysis]
2 Sodagar A, Javed R, Tahir H, Razak SIA, Shakir M, Naeem M, Yusof AHA, Sagadevan S, Hazafa A, Uddin J, Khan A, Al-harrasi A. Pathological Features and Neuroinflammatory Mechanisms of SARS-CoV-2 in the Brain and Potential Therapeutic Approaches. Biomolecules 2022;12:971. [DOI: 10.3390/biom12070971] [Reference Citation Analysis]
3 Dos Santos JMB, do Amaral JB, França CN, Monteiro FR, Alvares-Saraiva AM, Kalil S, Durigon EL, Oliveira DBL, Rodrigues SS, Heller D, Welter EAR, Pinho JRR, Vieira RP, Bachi ALL. Distinct Immunological Profiles Help in the Maintenance of Salivary Secretory IgA Production in Mild Symptoms COVID-19 Patients. Front Immunol 2022;13:890887. [PMID: 35686128 DOI: 10.3389/fimmu.2022.890887] [Reference Citation Analysis]
4 Sharif-zak M, Abbasi-jorjandi M, Asadikaram G, Ghoreshi Z, Rezazadeh-jabalbarzi M, afsharipur A, Rashidinejad H, Khajepour F, Jafarzadeh A, Arefinia N, Kheyrkhah A, Abolhassani M. CCR2 and DPP9 expression in the peripheral blood of COVID-19 patients: Influences of the disease severity and gender. Immunobiology 2022;227:152184. [DOI: 10.1016/j.imbio.2022.152184] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
5 Dong Y, Liu J, Lu N, Zhang C. Enterovirus 71 Antagonizes Antiviral Effects of Type III Interferon and Evades the Clearance of Intestinal Intraepithelial Lymphocytes. Front Microbiol 2021;12:806084. [PMID: 35185830 DOI: 10.3389/fmicb.2021.806084] [Reference Citation Analysis]
6 Sorrentino L, Silvestri V, Oliveto G, Scordio M, Frasca F, Fracella M, Bitossi C, D’auria A, Santinelli L, Gabriele L, Pierangeli A, Mastroianni CM, d’Ettorre G, Antonelli G, Caruz A, Ottini L, Scagnolari C. Distribution of Interferon Lambda 4 Single Nucleotide Polymorphism rs11322783 Genotypes in Patients with COVID-19. Microorganisms 2022;10:363. [DOI: 10.3390/microorganisms10020363] [Reference Citation Analysis]
7 Wirusanti NI, Baldridge MT, Harris VC. Microbiota regulation of viral infections through interferon signaling. Trends in Microbiology 2022. [DOI: 10.1016/j.tim.2022.01.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Hernández-Huerta MT, Pérez-Santiago AD, Pérez-Campos Mayoral L, Sánchez Navarro LM, Rodal Canales FJ, Majluf-Cruz A, Matias-Cervantes CA, Pérez-Campos Mayoral E, Romero Díaz C, Mayoral-Andrade G, Martínez Cruz M, Luna Ángel J, Pérez-Campos E. Mechanisms of Immunothrombosis by SARS-CoV-2. Biomolecules 2021;11:1550. [PMID: 34827548 DOI: 10.3390/biom11111550] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Jafarzadeh A, Jafarzadeh S, Nemati M. Therapeutic potential of ginger against COVID-19: Is there enough evidence? Journal of Traditional Chinese Medical Sciences 2021;8:267-79. [DOI: 10.1016/j.jtcms.2021.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zaman MS, Sizemore RC. Diverse Manifestations of COVID-19: Some Suggested Mechanisms. Int J Environ Res Public Health 2021;18:9785. [PMID: 34574709 DOI: 10.3390/ijerph18189785] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
11 Weber MS, Nicholas JA, Yeaman MR. Balancing Potential Benefits and Risks of Bruton Tyrosine Kinase Inhibitor Therapies in Multiple Sclerosis During the COVID-19 Pandemic. Neurol Neuroimmunol Neuroinflamm 2021;8:e1067. [PMID: 34497100 DOI: 10.1212/NXI.0000000000001067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Policard M, Jain S, Rego S, Dakshanamurthy S. Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism. Virus Res 2021;301:198464. [PMID: 34058265 DOI: 10.1016/j.virusres.2021.198464] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Rahman S, Montero MTV, Rowe K, Kirton R, Kunik F Jr. Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence. Expert Rev Clin Pharmacol 2021;14:601-21. [PMID: 33705239 DOI: 10.1080/17512433.2021.1902303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
14 Policard M, Jain S, Rego S, Dakshanamurthy S. Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism. bioRxiv 2021:2021. [PMID: 33619493 DOI: 10.1101/2021.02.17.431721] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Jafarzadeh A, Nemati M, Jafarzadeh S. Contribution of STAT3 to the pathogenesis of COVID-19. Microb Pathog 2021;154:104836. [PMID: 33691172 DOI: 10.1016/j.micpath.2021.104836] [Cited by in Crossref: 1] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
16 Dos Santos JMB, Soares CP, Monteiro FR, Mello R, do Amaral JB, Aguiar AS, Soledade MP, Sucupira C, De Paulis M, Andrade JB, Almeida FJ, Sáfadi MAP, Mau LB, Brasil JM, Ramalho T, Loures FV, Vieira RP, Durigon EL, de Oliveira DBL, Bachi ALL. In Nasal Mucosal Secretions, Distinct IFN and IgA Responses Are Found in Severe and Mild SARS-CoV-2 Infection. Front Immunol 2021;12:595343. [PMID: 33717074 DOI: 10.3389/fimmu.2021.595343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]